Viapath reports continued revenue growth

Viapath, the pathology provider previously known as GSTS Pathology, has reported an 8.7% increase in revenue to £114.3m for the year ended 31 December 2017 following the first full year of its contract to provide pathology services at Princess Royal University Hospital in Kent. However, activity volumes outpaced revenue growth, increasing by 11% and leading…

You must be a HM Subscriber to view this content. Please log in or subscribe below.

Subscribe Now »